Benlysta 120 mg
Benlysta 120 mg is a medicine authorised by Swissmedic under authorisation number 61532. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 14 June 2012 and the authorisation is valid without a time limit. ATC code L04AG04 places the medicine in the group Immunosuppressants.
| Authorisation number | 61532 |
|---|---|
| Name | Benlysta 120 mg |
| Full name | Benlysta 120 mg, Pulver zur Herstellung einer Infusionslösung |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L04AG04 |
| First authorisation | 14 June 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Benlysta 120 mg, Pulver zur Herstellung einer Infusionslösung | A | 14 June 2012 |
| 2 | Benlysta 400 mg, Pulver zur Herstellung einer Infusionslösung | A | 14 June 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L04AG04 | 07.15.0. | A |
| 2 | 1 | Durchstechflasche(n) | L04AG04 | 07.15.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Benlysta 120 mg authorised in Switzerland?
Yes. Benlysta 120 mg is authorised by Swissmedic under authorisation number 61532, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Benlysta 120 mg have?
Benlysta 120 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Benlysta 120 mg?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.